Online citations, reference lists, and bibliographies.
← Back to Search

Chitosan-coated Lipid Nanocarriers For Therapeutic Applications

F. Oyarzun-Ampuero, M. Garcia-Fuentes, Dolores Torres, M. Alonso
Published 2010 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
This article reports the efforts made over the last two decades by our group regarding the design of chitosan-coated lipid nanostructures as well as their potential for two different applications: i) as transmucosal delivery vehicles for complex macromolecules and ii) as carriers for anticancer drug delivery. The nanostructures described here share a core-coating structure, in which the core consists of a liquid (Miglyol 812) or a solid (tripalmitin) lipid surrounded by a chitosan coating. Both polymer-coated nanostructures have displayed outstanding properties in relation to the favored transport of large complex molecules (e.g. peptides and vaccines) across the nasal and intestinal barriers, as well as to facilitate the intracellular delivery of anticancer drugs into tumor cells.
This paper references
10.1023/A:1011922819926
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
10.1111/j.2042-7158.1994.tb03854.x
Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats
P. J. Lowe (1994)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I2.10
Nanocapsule technology: a review.
P. Couvreur (2002)
10.1021/LA049505J
Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles.
M. Garcia-Fuentes (2004)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1002/JPS.10573
Biodegradable nanoparticles containing protein‐fatty acid complexes for oral delivery of salmon calcitonin
H. Yoo (2004)
10.1023/A:1018977130559
Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol
C. Losa (2004)
10.1081/PDT-100100522
Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin
Y. Kawashima (2000)
10.1016/J.DRUDIS.2006.07.005
Exploiting the enhanced permeability and retention effect for tumor targeting.
A. Iyer (2006)
10.1007/978-1-4899-0768-4
Progress in Biomedical Polymers
C. G. Gebelein (1990)
10.1016/J.VACCINE.2005.07.053
Lipid microparticles for mucosal immunization against hepatitis B.
Surbhi Saraf (2006)
10.1111/j.2042-7158.1989.tb06377.x
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
P. Jani (1989)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1016/0378-5173(89)90272-X
An in vitro study of possible food-drug interactions of the controlled-release propranolol products
S. K. el-Arini (1989)
10.1016/S0928-0987(00)00065-8
Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements.
S. Rossi (2000)
10.1016/S0927-7765(02)00053-X
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
10.1111/j.2042-7158.1996.tb03911.x
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
P. Calvo (1996)
10.1016/S0168-3659(02)00411-X
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
10.1016/S0378-5173(00)00506-8
Lipid emulsions as vehicles for enhanced nasal delivery of insulin.
R. Mitra (2000)
10.1007/s10544-008-9209-0
Nanotechnology for breast cancer therapy
T. Tanaka (2009)
10.1016/j.addr.2008.09.005
Nanoparticles for nasal vaccination.
N. Csaba (2009)
10.1093/ANNONC/MDL104
Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.
M. Green (2006)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
10.1089/JOP.1986.2.353
Ocular disposition of inulin from single & multiple doses of positively charged multilamellar liposomes: evidence for alterations in tear dynamics and ocular surface characteristics.
V. Lee (1986)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1158/1535-7163.MCT-06-0289
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats
E. Garcion (2006)
10.1016/J.JCIS.2004.10.012
Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
M. Garcia-Fuentes (2005)
10.1023/A:1012029517394
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
A. Florence (2004)
10.1016/S0168-3659(02)00363-2
Nasal drug delivery--possibilities, problems and solutions.
L. Illum (2003)
10.1002/JPS.2600821102
Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization.
S. Benita (1993)
10.1016/S0928-0987(03)00178-7
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
A. M. de Campos (2003)
10.1186/1471-2407-7-189
Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study
Z. Jiang (2007)
10.1038/386410A0
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
10.1016/S0378-5173(01)00882-1
Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages.
N. Schöler (2002)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.1016/S0378-5173(97)04885-0
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
A. J. Almeida (1997)
10.1023/A:1018901302450
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
10.1007/S003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
H. Fessi (1989)
10.1093/ANNONC/MDM136
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
G. Ferrandina (2007)
10.1023/A:1016208125979
Poly(D,L-Lactide) Nanocapsules Containing Non-Steroidal Anti-Inflammatory Drugs: Gastrointestinal Tolerance Following Intravenous and Oral Administration
S. Guterres (2004)
10.1007/978-94-011-5942-5
Advances in chitin and chitosan
C. Brine (1992)
10.1016/0378-5173(93)90237-A
Positively charged submicron emulsions — a new type of colloidal drug carrier
E. Elbaz (1993)
10.1016/S0169-409X(00)00063-6
Oral delivery of salmon calcitonin.
Y. H. Lee (2000)
10.1016/0168-3659(95)00146-8
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
G. Borchard (1996)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1023/A:1016207809199
Effects of Absorption Enhancers on Rat Nasal Epithelium in Vivo: Release of Marker Compounds in the Nasal Cavity
E. Marttin (2004)
10.1016/S1773-2247(06)50061-9
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
10.1016/0378-5173(89)90030-6
Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine
D. Meisner (1989)
10.1016/S0378-5173(99)00451-2
Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
P. Tengamnuay (2000)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
10.1021/bm800298u
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
M. Lozano (2008)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1016/S0169-409X(01)00184-3
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
A. Florence (2001)
10.1016/0168-3659(93)90179-9
Absorption enhancers in nasal drug delivery: efficacy and safety
F. W. H. M. Merkus (1993)
10.1517/17425247.3.4.463
The performance of nanocarriers for transmucosal drug delivery
N. Csaba (2006)
10.1016/S0378-5173(03)00090-5
Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Prapasri Sinswat (2003)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1080/02652040400015411
Formulation and characterization of triclosan sub-micron emulsions and nanocapsules
F. Maestrelli (2004)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.3109/10611869609015973
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
R. Mueller (1996)
10.1159/000106841
Docetaxel Weekly with Metastatic Breast Cancer
C. Twelves (2007)
10.1021/JS950474+
Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
P. Calvo (1996)
10.1023/A:1019854327540
Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport
I. Behrens (2004)
10.3109/08982108909036000
Adhesion of Positively Charged Liposomes to Mucosal Tissues
L. S. Guo (1989)
10.1007/s11095-006-9570-8
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
C. Prego (2006)



This paper is referenced by
10.1371/journal.pone.0062500
A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach
S. Vicente (2013)
10.2217/nnm.14.159
Lipid nanoparticles for the topical delivery of retinoids and derivatives.
Javier O Morales (2015)
10.1016/j.ijpharm.2012.01.051
Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan.
E. A. Bender (2012)
10.1002/jps.24255
Association efficiency of three ionic forms of oxytetracycline to cationic and anionic oil-in-water nanoemulsions analyzed by diafiltration.
Sandra L. Orellana (2015)
10.1016/j.ijpharm.2018.11.028
Rethinking carbamazepine oral delivery using polymer‐lipid hybrid nanoparticles
R. Ana (2019)
10.2217/nnm-2019-0206
Design of polymeric nanocapsules to improve their lympho-targeting capacity.
J. Crecente-Campo (2019)
10.1002/btm2.10118
Engineering, on‐demand manufacturing, and scaling‐up of polymeric nanocapsules
J. Crecente-Campo (2019)
10.1081/E-ENN3-120051984
Surface-Modified Nanoparticles to Improve Drug Delivery
Felipe A Oyarzun-Ampuero (2014)
10.1016/j.vaccine.2014.01.059
Biodistribution and lymph node retention of polysaccharide-based immunostimulating nanocapsules.
Sara Vicente (2014)
10.1016/j.jconrel.2012.03.017
Chitosan-based drug nanocarriers: where do we stand?
M. Garcia-Fuentes (2012)
10.1016/J.TIFS.2016.05.005
Biodegradable polymers as wall materials to the synthesis of bioactive compound nanocapsules
P. Santos (2016)
10.1021/BK-2011-1091.CH010
Glyco-Nanoparticles as Platforms for Antitumor Therapeutic Strategies
J. Barchi (2011)
10.1002/9781119962977.CH1
Chemical and Technological Advances in Chitins and Chitosans Useful for the Formulation of Biopharmaceuticals
R. Muzzarelli (2012)
Semantic Scholar Logo Some data provided by SemanticScholar